Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
74.8 TRY | -0.27% | -9.33% | +96.22% |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 2.369 | 4.378 | 51.18 | 49.17 | 179.2 | 353.9 |
Enterprise Value (EV) 1 | 21.61 | 22.12 | 74.34 | 84.71 | 221.1 | 353.9 |
P/E ratio | -0.59 x | 1.41 x | 261 x | 3.48 x | 4.83 x | -16.4 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 0.05 x | 0.08 x | 1.16 x | 0.79 x | 1.47 x | 1.53 x |
EV / Revenue | 0.5 x | 0.38 x | 1.68 x | 1.36 x | 1.82 x | 1.53 x |
EV / EBITDA | -21.7 x | -14.2 x | -176 x | -43.6 x | -199 x | -88.8 x |
EV / FCF | 13.8 x | 8.86 x | -10.1 x | -115 x | -27 x | 61.7 x |
FCF Yield | 7.25% | 11.3% | -9.93% | -0.87% | -3.71% | 1.62% |
Price to Book | 0.38 x | 0.47 x | 4.71 x | 1.97 x | 2.33 x | 3.35 x |
Nbr of stocks (in thousands) | 7,178 | 7,178 | 7,178 | 7,178 | 9,284 | 9,284 |
Reference price 2 | 0.3300 | 0.6100 | 7.130 | 6.850 | 19.30 | 38.12 |
Announcement Date | 3/1/19 | 3/2/20 | 2/11/21 | 2/16/22 | 2/28/23 | 5/6/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 43.61 | 57.96 | 44.13 | 62.34 | 121.8 | 230.8 |
EBITDA 1 | -0.9937 | -1.556 | -0.4218 | -1.945 | -1.114 | -3.983 |
EBIT 1 | -1.646 | -2.076 | -0.6565 | -1.961 | -1.178 | -4.12 |
Operating Margin | -3.77% | -3.58% | -1.49% | -3.15% | -0.97% | -1.79% |
Earnings before Tax (EBT) 1 | -4.045 | 3.102 | 0.1962 | 14.11 | 37.11 | -22.62 |
Net income 1 | -4.045 | 3.102 | 0.1962 | 14.11 | 37.11 | -21.6 |
Net margin | -9.28% | 5.35% | 0.44% | 22.63% | 30.47% | -9.36% |
EPS 2 | -0.5636 | 0.4322 | 0.0273 | 1.966 | 3.997 | -2.326 |
Free Cash Flow 1 | 1.566 | 2.497 | -7.383 | -0.735 | -8.203 | 5.739 |
FCF margin | 3.59% | 4.31% | -16.73% | -1.18% | -6.74% | 2.49% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | 80.5% | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 3/1/19 | 3/2/20 | 2/11/21 | 2/16/22 | 2/28/23 | 5/6/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 19.2 | 17.7 | 23.2 | 35.5 | 41.9 | - |
Net Cash position 1 | - | - | - | - | - | 0.02 |
Leverage (Debt/EBITDA) | -19.36 x | -11.4 x | -54.92 x | -18.28 x | -37.66 x | - |
Free Cash Flow 1 | 1.57 | 2.5 | -7.38 | -0.74 | -8.2 | 5.74 |
ROE (net income / shareholders' equity) | -56.8% | 40% | 1.95% | 78.7% | 72.7% | -18.5% |
ROA (Net income/ Total Assets) | -2.55% | -2.95% | -0.85% | -1.84% | -0.69% | -1.49% |
Assets 1 | 158.6 | -105 | -23.09 | -767.5 | -5,412 | 1,451 |
Book Value Per Share 2 | 0.8700 | 1.290 | 1.510 | 3.480 | 8.300 | 11.40 |
Cash Flow per Share 2 | 0 | 0 | 0 | 0.3800 | 0.1000 | 0 |
Capex 1 | 0.03 | 0.01 | 0.03 | 0.02 | - | - |
Capex / Sales | 0.06% | 0.01% | 0.06% | 0.03% | - | - |
Announcement Date | 3/1/19 | 3/2/20 | 2/11/21 | 2/16/22 | 2/28/23 | 5/6/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+96.22% | 21.2M | |
-4.48% | 271B | |
-7.99% | 89.39B | |
-12.60% | 39.25B | |
-1.49% | 36.23B | |
-1.82% | 37.02B | |
-15.99% | 30B | |
-5.23% | 29.23B | |
+3.46% | 23.68B | |
-15.73% | 20.99B |
- Stock Market
- Equities
- EKIZ Stock
- Financials Ekiz Kimya Sanayi ve Ticaret Anonim Sirketi